nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—Carboplatin—brain cancer	0.446	0.652	CbGbCtD
Tolmetin—PTGS2—Etoposide—brain cancer	0.129	0.189	CbGbCtD
Tolmetin—PTGS1—Etoposide—brain cancer	0.109	0.16	CbGbCtD
Tolmetin—TDO2—pituitary gland—brain cancer	0.00566	0.0707	CbGeAlD
Tolmetin—MPO—endothelium—brain cancer	0.005	0.0625	CbGeAlD
Tolmetin—MPO—blood vessel—brain cancer	0.00461	0.0577	CbGeAlD
Tolmetin—Tolcapone—CYP2C9—brain cancer	0.00447	0.348	CrCbGaD
Tolmetin—TDO2—endocrine gland—brain cancer	0.00438	0.0548	CbGeAlD
Tolmetin—TDO2—head—brain cancer	0.00433	0.0541	CbGeAlD
Tolmetin—TDO2—central nervous system—brain cancer	0.00395	0.0494	CbGeAlD
Tolmetin—Visual disturbance—Lomustine—brain cancer	0.00392	0.0342	CcSEcCtD
Tolmetin—TDO2—brain—brain cancer	0.00313	0.0392	CbGeAlD
Tolmetin—CXCL8—pituitary gland—brain cancer	0.00311	0.039	CbGeAlD
Tolmetin—Zolpidem—CYP2C9—brain cancer	0.0031	0.242	CrCbGaD
Tolmetin—CXCL8—medulla oblongata—brain cancer	0.00301	0.0376	CbGeAlD
Tolmetin—Renal failure—Lomustine—brain cancer	0.00281	0.0245	CcSEcCtD
Tolmetin—Stomatitis—Lomustine—brain cancer	0.00279	0.0243	CcSEcCtD
Tolmetin—PTGS1—ganglion—brain cancer	0.00275	0.0344	CbGeAlD
Tolmetin—CXCL8—midbrain—brain cancer	0.00275	0.0344	CbGeAlD
Tolmetin—CXCL8—spinal cord—brain cancer	0.00268	0.0335	CbGeAlD
Tolmetin—Vascular purpura—Procarbazine—brain cancer	0.00264	0.023	CcSEcCtD
Tolmetin—Haemolytic anaemia—Procarbazine—brain cancer	0.00261	0.0228	CcSEcCtD
Tolmetin—Visual impairment—Lomustine—brain cancer	0.00248	0.0216	CcSEcCtD
Tolmetin—Purpura—Procarbazine—brain cancer	0.00245	0.0213	CcSEcCtD
Tolmetin—Blood urea increased—Hydroxyurea—brain cancer	0.00237	0.0207	CcSEcCtD
Tolmetin—PTGS1—endothelium—brain cancer	0.00237	0.0297	CbGeAlD
Tolmetin—Lumiracoxib—CYP2C9—brain cancer	0.00235	0.183	CrCbGaD
Tolmetin—PTGS2—endothelium—brain cancer	0.00227	0.0284	CbGeAlD
Tolmetin—PTGS1—blood vessel—brain cancer	0.00219	0.0274	CbGeAlD
Tolmetin—CXCL8—cerebellum—brain cancer	0.00212	0.0266	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00212	0.0185	CcSEcCtD
Tolmetin—PTGS2—blood vessel—brain cancer	0.00209	0.0261	CbGeAlD
Tolmetin—MPO—pituitary gland—brain cancer	0.00182	0.0228	CbGeAlD
Tolmetin—Drowsiness—Procarbazine—brain cancer	0.00182	0.0158	CcSEcCtD
Tolmetin—Thrombocytopenia—Lomustine—brain cancer	0.00179	0.0156	CcSEcCtD
Tolmetin—Suprofen—CYP2C9—brain cancer	0.00178	0.139	CrCbGaD
Tolmetin—Stomatitis—Procarbazine—brain cancer	0.00177	0.0154	CcSEcCtD
Tolmetin—Haematuria—Procarbazine—brain cancer	0.00173	0.0151	CcSEcCtD
Tolmetin—CXCL8—brain—brain cancer	0.00173	0.0216	CbGeAlD
Tolmetin—Epistaxis—Procarbazine—brain cancer	0.00171	0.0149	CcSEcCtD
Tolmetin—Body temperature increased—Carboplatin—brain cancer	0.00165	0.0144	CcSEcCtD
Tolmetin—Vascular purpura—Temozolomide—brain cancer	0.00159	0.0139	CcSEcCtD
Tolmetin—MPO—spinal cord—brain cancer	0.00157	0.0196	CbGeAlD
Tolmetin—Purpura—Temozolomide—brain cancer	0.00148	0.0129	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00148	0.0129	CcSEcCtD
Tolmetin—Dysuria—Hydroxyurea—brain cancer	0.00147	0.0129	CcSEcCtD
Tolmetin—Body temperature increased—Lomustine—brain cancer	0.00144	0.0126	CcSEcCtD
Tolmetin—Weight increased—Hydroxyurea—brain cancer	0.00144	0.0125	CcSEcCtD
Tolmetin—MPO—endocrine gland—brain cancer	0.00141	0.0176	CbGeAlD
Tolmetin—Drowsiness—Hydroxyurea—brain cancer	0.00141	0.0123	CcSEcCtD
Tolmetin—MPO—head—brain cancer	0.00139	0.0174	CbGeAlD
Tolmetin—Stomatitis—Hydroxyurea—brain cancer	0.00137	0.0119	CcSEcCtD
Tolmetin—SLC22A6—brain—brain cancer	0.00135	0.0169	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00128	0.0112	CcSEcCtD
Tolmetin—MPO—central nervous system—brain cancer	0.00127	0.0159	CbGeAlD
Tolmetin—Cardiac failure congestive—Etoposide—brain cancer	0.00126	0.011	CcSEcCtD
Tolmetin—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00126	0.0117	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—HES5—brain cancer	0.00126	0.0117	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CDK6—brain cancer	0.00125	0.0116	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—VAV1—brain cancer	0.00122	0.0114	CbGpPWpGaD
Tolmetin—CXCL8—IL8- and CXCR1-mediated signaling events—PIK3CG—brain cancer	0.00121	0.0113	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CDK4—brain cancer	0.00119	0.011	CbGpPWpGaD
Tolmetin—Anaphylactoid reaction—Etoposide—brain cancer	0.00118	0.0103	CcSEcCtD
Tolmetin—Vomiting—Lomustine—brain cancer	0.00116	0.0101	CcSEcCtD
Tolmetin—Oedema—Procarbazine—brain cancer	0.00116	0.0101	CcSEcCtD
Tolmetin—Dysuria—Temozolomide—brain cancer	0.00115	0.01	CcSEcCtD
Tolmetin—Thrombocytopenia—Procarbazine—brain cancer	0.00113	0.00989	CcSEcCtD
Tolmetin—Indomethacin—CYP2C9—brain cancer	0.00113	0.0882	CrCbGaD
Tolmetin—Weight increased—Temozolomide—brain cancer	0.00112	0.00977	CcSEcCtD
Tolmetin—Renal failure—Carmustine—brain cancer	0.00112	0.00974	CcSEcCtD
Tolmetin—Weight decreased—Temozolomide—brain cancer	0.00111	0.00971	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—SOD2—brain cancer	0.00111	0.0104	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00111	0.0103	CbGpPWpGaD
Tolmetin—Stomatitis—Carmustine—brain cancer	0.00111	0.00966	CcSEcCtD
Tolmetin—CXCL8—EBV LMP1 signaling—RELA—brain cancer	0.00111	0.0103	CbGpPWpGaD
Tolmetin—Urinary tract infection—Carmustine—brain cancer	0.00111	0.00963	CcSEcCtD
Tolmetin—Nausea—Lomustine—brain cancer	0.00108	0.00945	CcSEcCtD
Tolmetin—Stomatitis—Temozolomide—brain cancer	0.00107	0.00933	CcSEcCtD
Tolmetin—Urinary tract infection—Temozolomide—brain cancer	0.00107	0.00931	CcSEcCtD
Tolmetin—PTGS1—telencephalon—brain cancer	0.00106	0.0133	CbGeAlD
Tolmetin—CXCL8—Spinal Cord Injury—GFAP—brain cancer	0.00106	0.00984	CbGpPWpGaD
Tolmetin—CXCL8—IL8- and CXCR2-mediated signaling events—PIK3CG—brain cancer	0.00104	0.00966	CbGpPWpGaD
Tolmetin—Somnolence—Procarbazine—brain cancer	0.00103	0.00898	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00103	0.00895	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—RELA—brain cancer	0.00102	0.00951	CbGpPWpGaD
Tolmetin—PTGS2—telencephalon—brain cancer	0.00101	0.0127	CbGeAlD
Tolmetin—MPO—brain—brain cancer	0.00101	0.0126	CbGeAlD
Tolmetin—Constipation—Procarbazine—brain cancer	0.000991	0.00864	CcSEcCtD
Tolmetin—Hepatitis—Temozolomide—brain cancer	0.000986	0.00859	CcSEcCtD
Tolmetin—Visual impairment—Carmustine—brain cancer	0.000984	0.00857	CcSEcCtD
Tolmetin—Visual impairment—Temozolomide—brain cancer	0.000951	0.00828	CcSEcCtD
Tolmetin—Gastrointestinal pain—Procarbazine—brain cancer	0.000948	0.00826	CcSEcCtD
Tolmetin—Erythema multiforme—Temozolomide—brain cancer	0.000933	0.00813	CcSEcCtD
Tolmetin—Urticaria—Procarbazine—brain cancer	0.000921	0.00802	CcSEcCtD
Tolmetin—Tinnitus—Temozolomide—brain cancer	0.00092	0.00801	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL2—brain cancer	0.000919	0.00856	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HES1—brain cancer	0.000918	0.00855	CbGpPWpGaD
Tolmetin—Abdominal pain—Procarbazine—brain cancer	0.000916	0.00798	CcSEcCtD
Tolmetin—Body temperature increased—Procarbazine—brain cancer	0.000916	0.00798	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—CDKN2A—brain cancer	0.000906	0.00844	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—HES1—brain cancer	0.000903	0.00842	CbGpPWpGaD
Tolmetin—Oedema—Hydroxyurea—brain cancer	0.000897	0.00782	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—SOD2—brain cancer	0.000883	0.00823	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000878	0.00765	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—ERBB2—brain cancer	0.000866	0.00807	CbGpPWpGaD
Tolmetin—Renal failure—Etoposide—brain cancer	0.000864	0.00753	CcSEcCtD
Tolmetin—PTGS1—pituitary gland—brain cancer	0.000864	0.0108	CbGeAlD
Tolmetin—CXCL8—ATF-2 transcription factor network—PDGFRA—brain cancer	0.00086	0.00801	CbGpPWpGaD
Tolmetin—Stomatitis—Etoposide—brain cancer	0.000857	0.00747	CcSEcCtD
Tolmetin—Asthenia—Procarbazine—brain cancer	0.000832	0.00725	CcSEcCtD
Tolmetin—PTGS2—pituitary gland—brain cancer	0.000826	0.0103	CbGeAlD
Tolmetin—Agranulocytosis—Etoposide—brain cancer	0.00082	0.00715	CcSEcCtD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—EGFR—brain cancer	0.00082	0.00764	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000808	0.00754	CbGpPWpGaD
Tolmetin—Somnolence—Hydroxyurea—brain cancer	0.000797	0.00695	CcSEcCtD
Tolmetin—PTGS2—medulla oblongata—brain cancer	0.000797	0.00997	CbGeAlD
Tolmetin—Diarrhoea—Procarbazine—brain cancer	0.000793	0.00691	CcSEcCtD
Tolmetin—Dyspepsia—Hydroxyurea—brain cancer	0.00079	0.00688	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—RELA—brain cancer	0.000789	0.00736	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—brain cancer	0.000786	0.00733	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDK6—brain cancer	0.000774	0.00722	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—STAT3—brain cancer	0.000773	0.00721	CbGpPWpGaD
Tolmetin—Constipation—Hydroxyurea—brain cancer	0.000767	0.00668	CcSEcCtD
Tolmetin—Dizziness—Procarbazine—brain cancer	0.000766	0.00668	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—CCND1—brain cancer	0.000765	0.00713	CbGpPWpGaD
Tolmetin—Chest pain—Carmustine—brain cancer	0.000756	0.00659	CcSEcCtD
Tolmetin—Erythema multiforme—Etoposide—brain cancer	0.000746	0.0065	CcSEcCtD
Tolmetin—PTGS1—spinal cord—brain cancer	0.000743	0.0093	CbGeAlD
Tolmetin—Vomiting—Procarbazine—brain cancer	0.000737	0.00642	CcSEcCtD
Tolmetin—PTGS2—midbrain—brain cancer	0.000728	0.00911	CbGeAlD
Tolmetin—Headache—Procarbazine—brain cancer	0.000726	0.00633	CcSEcCtD
Tolmetin—Oedema—Carmustine—brain cancer	0.000725	0.00632	CcSEcCtD
Tolmetin—PTGS2—spinal cord—brain cancer	0.000711	0.00889	CbGeAlD
Tolmetin—Thrombocytopenia—Carmustine—brain cancer	0.00071	0.00619	CcSEcCtD
Tolmetin—Body temperature increased—Hydroxyurea—brain cancer	0.000709	0.00618	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—CDK4—brain cancer	0.000708	0.0066	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Temozolomide—brain cancer	0.000701	0.00611	CcSEcCtD
Tolmetin—Oedema—Temozolomide—brain cancer	0.000701	0.00611	CcSEcCtD
Tolmetin—Nausea—Procarbazine—brain cancer	0.000688	0.006	CcSEcCtD
Tolmetin—Thrombocytopenia—Temozolomide—brain cancer	0.000686	0.00598	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—PDGFRA—brain cancer	0.000681	0.00634	CbGpPWpGaD
Tolmetin—PTGS1—endocrine gland—brain cancer	0.000669	0.00837	CbGeAlD
Tolmetin—CXCL8—Bladder Cancer—VEGFA—brain cancer	0.000667	0.00622	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—brain cancer	0.000664	0.00619	CbGpPWpGaD
Tolmetin—PTGS1—head—brain cancer	0.000661	0.00826	CbGeAlD
Tolmetin—Somnolence—Carmustine—brain cancer	0.000645	0.00562	CcSEcCtD
Tolmetin—Asthenia—Hydroxyurea—brain cancer	0.000644	0.00561	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—RELA—brain cancer	0.000642	0.00598	CbGpPWpGaD
Tolmetin—PTGS2—endocrine gland—brain cancer	0.00064	0.008	CbGeAlD
Tolmetin—PTGS2—head—brain cancer	0.000632	0.0079	CbGeAlD
Tolmetin—CXCL8—TSLP Signaling Pathway—RELA—brain cancer	0.000625	0.00582	CbGpPWpGaD
Tolmetin—Somnolence—Temozolomide—brain cancer	0.000623	0.00543	CcSEcCtD
Tolmetin—Constipation—Carmustine—brain cancer	0.00062	0.0054	CcSEcCtD
Tolmetin—Dyspepsia—Temozolomide—brain cancer	0.000617	0.00537	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—MYC—brain cancer	0.000614	0.00572	CbGpPWpGaD
Tolmetin—Diarrhoea—Hydroxyurea—brain cancer	0.000614	0.00535	CcSEcCtD
Tolmetin—PTGS1—central nervous system—brain cancer	0.000603	0.00754	CbGeAlD
Tolmetin—CXCL8—Bladder Cancer—EGFR—brain cancer	0.0006	0.0056	CbGpPWpGaD
Tolmetin—Constipation—Temozolomide—brain cancer	0.000599	0.00522	CcSEcCtD
Tolmetin—Dizziness—Hydroxyurea—brain cancer	0.000593	0.00517	CcSEcCtD
Tolmetin—Gastrointestinal pain—Carmustine—brain cancer	0.000593	0.00517	CcSEcCtD
Tolmetin—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000589	0.00549	CbGpPWpGaD
Tolmetin—Chest pain—Etoposide—brain cancer	0.000585	0.0051	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL2—brain cancer	0.000578	0.00539	CbGpPWpGaD
Tolmetin—PTGS2—central nervous system—brain cancer	0.000576	0.00721	CbGeAlD
Tolmetin—Abdominal pain—Carmustine—brain cancer	0.000573	0.00499	CcSEcCtD
Tolmetin—Body temperature increased—Carmustine—brain cancer	0.000573	0.00499	CcSEcCtD
Tolmetin—Gastrointestinal pain—Temozolomide—brain cancer	0.000573	0.00499	CcSEcCtD
Tolmetin—Vomiting—Hydroxyurea—brain cancer	0.00057	0.00497	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—PTCH2—brain cancer	0.000565	0.00527	CbGpPWpGaD
Tolmetin—PTGS2—cerebellum—brain cancer	0.000563	0.00705	CbGeAlD
Tolmetin—Headache—Hydroxyurea—brain cancer	0.000562	0.0049	CcSEcCtD
Tolmetin—Anaphylactic shock—Etoposide—brain cancer	0.000561	0.00489	CcSEcCtD
Tolmetin—Urticaria—Temozolomide—brain cancer	0.000557	0.00485	CcSEcCtD
Tolmetin—Abdominal pain—Temozolomide—brain cancer	0.000554	0.00483	CcSEcCtD
Tolmetin—Body temperature increased—Temozolomide—brain cancer	0.000554	0.00483	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CDKN2A—brain cancer	0.00055	0.00513	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Etoposide—brain cancer	0.000549	0.00478	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—SPP1—brain cancer	0.000539	0.00502	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000536	0.00499	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000534	0.00498	CbGpPWpGaD
Tolmetin—Nausea—Hydroxyurea—brain cancer	0.000533	0.00464	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000523	0.00487	CbGpPWpGaD
Tolmetin—Asthenia—Carmustine—brain cancer	0.00052	0.00453	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—PCNA—brain cancer	0.000517	0.00482	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—RELA—brain cancer	0.00051	0.00475	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—TP53—brain cancer	0.000504	0.0047	CbGpPWpGaD
Tolmetin—Asthenia—Temozolomide—brain cancer	0.000503	0.00438	CcSEcCtD
Tolmetin—Somnolence—Etoposide—brain cancer	0.000498	0.00434	CcSEcCtD
Tolmetin—Diarrhoea—Carmustine—brain cancer	0.000496	0.00432	CcSEcCtD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000496	0.00462	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—OR4C12—brain cancer	0.000496	0.00462	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—OR14C36—brain cancer	0.000496	0.00462	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDK6—brain cancer	0.00049	0.00457	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—RELA—brain cancer	0.000488	0.00455	CbGpPWpGaD
Tolmetin—Dizziness—Carmustine—brain cancer	0.00048	0.00418	CcSEcCtD
Tolmetin—Constipation—Etoposide—brain cancer	0.00048	0.00418	CcSEcCtD
Tolmetin—Diarrhoea—Temozolomide—brain cancer	0.000479	0.00418	CcSEcCtD
Tolmetin—PTGS1—brain—brain cancer	0.000479	0.00599	CbGeAlD
Tolmetin—CXCL8—TSLP Signaling Pathway—STAT3—brain cancer	0.000474	0.00441	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN2A—brain cancer	0.000472	0.0044	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP2C9—brain cancer	0.000469	0.00437	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CCND1—brain cancer	0.000465	0.00433	CbGpPWpGaD
Tolmetin—Dizziness—Temozolomide—brain cancer	0.000463	0.00404	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000463	0.00431	CbGpPWpGaD
Tolmetin—Vomiting—Carmustine—brain cancer	0.000461	0.00402	CcSEcCtD
Tolmetin—Gastrointestinal pain—Etoposide—brain cancer	0.000459	0.004	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—STAT3—brain cancer	0.000458	0.00427	CbGpPWpGaD
Tolmetin—PTGS2—brain—brain cancer	0.000458	0.00572	CbGeAlD
Tolmetin—CXCL8—ATF-2 transcription factor network—CCND1—brain cancer	0.000457	0.00426	CbGpPWpGaD
Tolmetin—Headache—Carmustine—brain cancer	0.000454	0.00396	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—OR4C12—brain cancer	0.00045	0.0042	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—OR14C36—brain cancer	0.00045	0.0042	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDK4—brain cancer	0.000447	0.00416	CbGpPWpGaD
Tolmetin—Vomiting—Temozolomide—brain cancer	0.000446	0.00388	CcSEcCtD
Tolmetin—Urticaria—Etoposide—brain cancer	0.000445	0.00388	CcSEcCtD
Tolmetin—Abdominal pain—Etoposide—brain cancer	0.000443	0.00386	CcSEcCtD
Tolmetin—Body temperature increased—Etoposide—brain cancer	0.000443	0.00386	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—MYC—brain cancer	0.00044	0.0041	CbGpPWpGaD
Tolmetin—Headache—Temozolomide—brain cancer	0.000439	0.00382	CcSEcCtD
Tolmetin—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000432	0.00403	CbGpPWpGaD
Tolmetin—Nausea—Carmustine—brain cancer	0.000431	0.00375	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—PIK3CG—brain cancer	0.00043	0.00401	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000424	0.00395	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—SPP1—brain cancer	0.000421	0.00392	CbGpPWpGaD
Tolmetin—Nausea—Temozolomide—brain cancer	0.000416	0.00363	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—HES1—brain cancer	0.000415	0.00387	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—brain cancer	0.000409	0.00381	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDK4—brain cancer	0.000407	0.00379	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000405	0.00378	CbGpPWpGaD
Tolmetin—Asthenia—Etoposide—brain cancer	0.000402	0.00351	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.0004	0.00373	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CCND1—brain cancer	0.000399	0.00372	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—BSG—brain cancer	0.000399	0.00372	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CTNNB1—brain cancer	0.000395	0.00368	CbGpPWpGaD
Tolmetin—Diarrhoea—Etoposide—brain cancer	0.000384	0.00334	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—MYC—brain cancer	0.000373	0.00348	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL2—brain cancer	0.000371	0.00346	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—brain cancer	0.000371	0.00346	CbGpPWpGaD
Tolmetin—Dizziness—Etoposide—brain cancer	0.000371	0.00323	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—CDK6—brain cancer	0.00037	0.00345	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CCNE1—brain cancer	0.000369	0.00344	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—RELA—brain cancer	0.000365	0.0034	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000363	0.00338	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000361	0.00337	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000361	0.00336	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000358	0.00334	CbGpPWpGaD
Tolmetin—Vomiting—Etoposide—brain cancer	0.000357	0.00311	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000355	0.00331	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000354	0.0033	CbGpPWpGaD
Tolmetin—Headache—Etoposide—brain cancer	0.000351	0.00306	CcSEcCtD
Tolmetin—TDO2—Metabolism—IDH1—brain cancer	0.000343	0.0032	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN2A—brain cancer	0.000341	0.00318	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—brain cancer	0.000341	0.00318	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—brain cancer	0.000336	0.00313	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—RELA—brain cancer	0.000336	0.00313	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CG—brain cancer	0.000336	0.00313	CbGpPWpGaD
Tolmetin—Nausea—Etoposide—brain cancer	0.000333	0.0029	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—brain cancer	0.000329	0.00306	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—RELA—brain cancer	0.000328	0.00306	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000321	0.00299	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MYC—brain cancer	0.00032	0.00298	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000317	0.00296	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—brain cancer	0.000316	0.00294	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000298	0.00278	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—SHH—brain cancer	0.000291	0.00271	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTCH2—brain cancer	0.00029	0.0027	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000288	0.00268	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.000287	0.00267	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDK4—brain cancer	0.000283	0.00263	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—SIRT1—brain cancer	0.000282	0.00263	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CCNE1—brain cancer	0.000279	0.0026	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000278	0.0026	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PTCH1—brain cancer	0.000276	0.00257	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—SMO—brain cancer	0.000276	0.00257	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—SOD2—brain cancer	0.000272	0.00253	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ENO2—brain cancer	0.000271	0.00253	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—brain cancer	0.000269	0.00251	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—OR4C12—brain cancer	0.000266	0.00248	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—OR14C36—brain cancer	0.000266	0.00248	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—brain cancer	0.000263	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CCND1—brain cancer	0.000263	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	0.000262	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ABR—brain cancer	0.000251	0.00234	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—STAT3—brain cancer	0.000249	0.00232	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000249	0.00232	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000236	0.0022	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000235	0.00219	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000231	0.00216	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ABR—brain cancer	0.000228	0.00212	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000226	0.00211	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DTX2—brain cancer	0.000226	0.00211	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN2A—brain cancer	0.000216	0.00201	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDK4—brain cancer	0.000214	0.00199	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000213	0.00199	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MYC—brain cancer	0.000211	0.00196	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	0.000209	0.00195	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000208	0.00194	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—RELA—brain cancer	0.000208	0.00194	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—brain cancer	0.000206	0.00192	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.0002	0.00187	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000199	0.00186	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000196	0.00183	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000192	0.00179	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—brain cancer	0.00019	0.00177	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000183	0.00171	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00018	0.00167	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	0.000179	0.00167	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDK4—brain cancer	0.000178	0.00166	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—brain cancer	0.000173	0.00161	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTCH2—brain cancer	0.000171	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HES5—brain cancer	0.000166	0.00155	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	0.000166	0.00154	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000166	0.00154	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000163	0.00152	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—brain cancer	0.000163	0.00152	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STRADA—brain cancer	0.000161	0.0015	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00016	0.00149	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—TRPC6—brain cancer	0.000159	0.00148	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000158	0.00148	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—STAT3—brain cancer	0.000158	0.00147	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RELA—brain cancer	0.000157	0.00146	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	0.000151	0.00141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—SHH—brain cancer	0.000149	0.00139	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000148	0.00138	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000147	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TRPC6—brain cancer	0.000144	0.00134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTCH1—brain cancer	0.000142	0.00132	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—SMO—brain cancer	0.000142	0.00132	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DTX2—brain cancer	0.000141	0.00132	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00014	0.00131	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ABR—brain cancer	0.000134	0.00125	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000131	0.00122	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GLI2—brain cancer	0.00013	0.00121	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CG—brain cancer	0.000124	0.00116	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GLI1—brain cancer	0.000122	0.00114	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000121	0.00113	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—brain cancer	0.000121	0.00113	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—brain cancer	0.00012	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—brain cancer	0.00012	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—brain cancer	0.000119	0.00111	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—VAV1—brain cancer	0.000119	0.00111	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—brain cancer	0.000118	0.0011	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SUFU—brain cancer	0.000116	0.00108	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—brain cancer	0.000115	0.00107	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000114	0.00106	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GFAP—brain cancer	0.000112	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—VAV1—brain cancer	0.000108	0.00101	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HEY1—brain cancer	0.000106	0.000987	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DLL1—brain cancer	0.000104	0.000968	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HES5—brain cancer	0.000104	0.000968	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP2C9—brain cancer	0.000101	0.00094	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—brain cancer	9.23e-05	0.00086	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—brain cancer	9.08e-05	0.000847	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—brain cancer	9.03e-05	0.000841	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.86e-05	0.000826	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SHH—brain cancer	8.83e-05	0.000823	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BSG—brain cancer	8.57e-05	0.000799	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TRPC6—brain cancer	8.51e-05	0.000794	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMO—brain cancer	8.37e-05	0.00078	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTCH1—brain cancer	8.37e-05	0.00078	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2C9—brain cancer	8e-05	0.000746	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.83e-05	0.00073	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.75e-05	0.000722	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—brain cancer	7.58e-05	0.000706	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CG—brain cancer	7.55e-05	0.000704	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—IDH1—brain cancer	7.37e-05	0.000687	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IDH1—brain cancer	6.99e-05	0.000651	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CG—brain cancer	6.86e-05	0.000639	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.82e-05	0.000636	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BSG—brain cancer	6.8e-05	0.000634	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH2—brain cancer	6.69e-05	0.000624	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HEY1—brain cancer	6.62e-05	0.000617	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DLL1—brain cancer	6.5e-05	0.000605	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—brain cancer	6.38e-05	0.000595	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VAV1—brain cancer	6.38e-05	0.000595	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.28e-05	0.000585	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.14e-05	0.000572	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6e-05	0.000559	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH1—brain cancer	5.85e-05	0.000545	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ENO2—brain cancer	5.83e-05	0.000543	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SHH—brain cancer	5.52e-05	0.000515	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ENO2—brain cancer	5.52e-05	0.000515	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HES1—brain cancer	5.49e-05	0.000511	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—brain cancer	5.31e-05	0.000495	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFRA—brain cancer	5.22e-05	0.000487	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.16e-05	0.000481	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPP1—brain cancer	5.07e-05	0.000473	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—brain cancer	4.82e-05	0.00045	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.76e-05	0.000444	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ENO2—brain cancer	4.63e-05	0.000431	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IRS2—brain cancer	4.59e-05	0.000427	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—brain cancer	4.05e-05	0.000378	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—brain cancer	4.05e-05	0.000378	CbGpPWpGaD
Tolmetin—PTGS2—Disease—VAV1—brain cancer	3.99e-05	0.000372	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—brain cancer	3.69e-05	0.000344	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HES1—brain cancer	3.43e-05	0.00032	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFRA—brain cancer	3.27e-05	0.000305	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RELA—brain cancer	3.16e-05	0.000295	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—brain cancer	3.14e-05	0.000293	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IRS2—brain cancer	2.87e-05	0.000267	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—brain cancer	2.85e-05	0.000266	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—brain cancer	2.78e-05	0.000259	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—brain cancer	2.75e-05	0.000256	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—brain cancer	2.67e-05	0.000249	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—brain cancer	2.53e-05	0.000236	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—brain cancer	2.42e-05	0.000226	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—brain cancer	2.4e-05	0.000224	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—brain cancer	2.23e-05	0.000208	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—brain cancer	2.18e-05	0.000203	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—brain cancer	2.12e-05	0.000198	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—brain cancer	1.97e-05	0.000183	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—brain cancer	1.83e-05	0.000171	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—brain cancer	1.72e-05	0.00016	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—brain cancer	1.5e-05	0.00014	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—brain cancer	1.39e-05	0.00013	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—brain cancer	1.36e-05	0.000127	CbGpPWpGaD
